Funding for this research was provided by:
World Bank Group
Government of the Republic of Kenya (IRG SERU 3236)
Received: 10 June 2019
Accepted: 24 November 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: The study was part of a bigger study (Protocol SSC 2276/3236) in the Kenya medical research institute entitled “Efficacy of artemisinin-based combination therapy (ACT) in Kenya.” The present study (Protocol SSC 3699) was approved on 5th September 2018 by the scientific review unit of the Kenya Medical Research Institute.
: The consent for publication was granted by the KEMRI publications review unit for the Director General KEMRI.
: The authors declare that they have no competing interests.